Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

AIDS-Related Complex × Dacarbazine × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 49 Lymphoma 19 Recurrence 2 Neoplasms 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Hematologic Diseases 1 HIV Infections 1 Acquired Immunodeficiency Syndrome 1 AIDS-Related Complex 1

Interventions

tetulomab tetraxetan lu-177 1 Zidovudine 1 Vinblastine 1 Lutetium 1 Filgrastim 1 Doxorubicin 1 Dacarbazine 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00000626 2021-10-27

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Hodgkin Disease, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡